(SNDX) Syndax Pharmaceuticals - Performance -59.6% in 12m
SNDX performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-39.51%
#59 in Peer-Group
Rel. Strength
6.94%
#7152 in Stock-Universe
Total Return 12m
-59.60%
#146 in Peer-Group
Total Return 5y
-29.14%
#48 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 24.81 USD |
| 52 Week Low | 8.73 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 73.34 |
| Buy/Sell Signal +-5 | 1.46 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: SNDX (-59.6%) vs XBI (-11.6%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
1.14% | 63.4% | 78.7% | 24.1 | 14.3 | 0.24 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
3.16% | -9.04% | 157% | 12 | 11 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
0.5% | -7.13% | 36% | 27.4 | 14.2 | 0.99 | 0.60% | 41% |
| NBIX NASDAQ Neurocrine Biosciences |
8.1% | -8.36% | 1.32% | 45.7 | 26.2 | 0.27 | 18.7% | -34.3% |
| BIM PA Biomerieux |
-0.99% | 26.5% | -5.28% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
8.81% | 38.5% | -10.4% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.65% | 49.3% | -10.3% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
-1.76% | 27.6% | 14.6% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: SNDX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for SNDX
| Total Return (including Dividends) | SNDX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -1.40% | 5.89% | 3.98% |
| 3 Months | -12.37% | 15.34% | 16.24% |
| 12 Months | -59.60% | -11.61% | 12.66% |
| 5 Years | -29.14% | -23.80% | 109.18% |
| Trend Score (consistency of price movement) | SNDX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -39% | 65.7% | 91.4% |
| 3 Months | -73.8% | 79.4% | 97.5% |
| 12 Months | -93.3% | -87.3% | 46.7% |
| 5 Years | -16.3% | -51.8% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th28.50 | -6.88% | -5.18% |
| 3 Month | %th14.00 | -24.02% | -24.61% |
| 12 Month | %th27.00 | -54.29% | -64.14% |
| 5 Years | %th76.50 | -7.01% | -66.12% |
FAQs
Does Syndax Pharmaceuticals (SNDX) outperform the market?
No,
over the last 12 months SNDX made -59.60%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.61%.
Over the last 3 months SNDX made -12.37%, while XBI made 15.34%.
Performance Comparison SNDX vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
SNDX vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 12.2% | -5.4% | -29.8% | -72% |
| US NASDAQ 100 | QQQ | 12.1% | -5.6% | -32.2% | -72% |
| German DAX 40 | DAX | 12.4% | -3.4% | -40.5% | -89% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 10.7% | -6.6% | -31.7% | -79% |
| Hongkong Hang Seng | HSI | 11.4% | -4% | -51.1% | -94% |
| India NIFTY 50 | INDA | 13.6% | -2.1% | -29.7% | -56% |
| Brasil Bovespa | EWZ | 17.3% | 2.1% | -42.9% | -60% |
SNDX vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 12.8% | -4.3% | -34.5% | -85% |
| Consumer Discretionary | XLY | 11.1% | -5.5% | -22.6% | -77% |
| Consumer Staples | XLP | 14.3% | -1.7% | -28.9% | -67% |
| Energy | XLE | 10.6% | -2.6% | -20% | -59% |
| Financial | XLF | 13.1% | -5.8% | -31.5% | -84% |
| Health Care | XLV | 12.3% | -1.4% | -19.1% | -53% |
| Industrial | XLI | 11.4% | -6.9% | -34.8% | -82% |
| Materials | XLB | 12.3% | -5.2% | -28.4% | -62% |
| Real Estate | XLRE | 11.9% | -2.1% | -28% | -67% |
| Technology | XLK | 12.6% | -6.8% | -34.5% | -69% |
| Utilities | XLU | 11.9% | -4.3% | -32.8% | -82% |
| Aerospace & Defense | XAR | 9.8% | -11.3% | -50.4% | -109% |
| Biotech | XBI | 7.2% | -7.3% | -23.7% | -48% |
| Homebuilder | XHB | 10% | -10.7% | -19.6% | -56% |
| Retail | XRT | 11.8% | -6.5% | -26.5% | -67% |
SNDX vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 14% | 2.38% | -14.4% | -54% |
| Natural Gas | UNG | 11.6% | 8.6% | -4.6% | -65% |
| Gold | GLD | 12.6% | -0.2% | -46.5% | -97% |
| Silver | SLV | 9.2% | -6.2% | -49.2% | -83% |
| Copper | CPER | 2.8% | -14.9% | -47.7% | -82% |
SNDX vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 13.5% | -2% | -24.4% | -56% |
| iShares High Yield Corp. Bond | HYG | 12.8% | -2.6% | -26.7% | -68% |